TWST's free cash flow for Q1 2024 was $-24.48M. For the 2024 fiscal year, TWST's free cash flow was decreased by $55.99M and operating cash flow was $-22.97M. See a summary of the company’s cash flow.

Cash Flow	TTM	Sep 23	Sep 22	Sep 21	Sep 20	Sep 19
Operating Cash Flow	$ -111.38M	$ -142.47M	$ -124.39M	$ -112.19M	$ -142.25M	$ -87.94M
Investing Cash Flow	$ 61.75M	$ 50.61M	$ -232.93M	$ 156.16M	$ -114.65M	$ -104.81M
Financing Cash Flow	$ -167.00K	$ 911.00K	$ 270.53M	$ 329.18M	$ 303.73M	$ 158.58M
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	$ 1.19B	$ 289.28M	$ 380.25M	$ 467.41M	$ 94.25M	$ 47.40M
Income Tax Paid Supplemental Data	$ 408.00K	$ 420.00K	$ 246.00K	$ 101.00K	$ 172.00K	$ 291.00K
Interest Paid Supplemental Data	-	-	$ 9.00K	$ 167.00K	$ 438.00K	$ 779.00K
Issuance Of Capital Stock	-	-	$ 269.82M	$ 323.86M	$ 295.56M	$ 156.21M
Issuance Of Debt	-	-	$ -1.56M	$ -3.33M	-	$ 0.00
Repayment Of Debt	-	-	$ -1.56M	$ -3.33M	$ -3.33M	$ -2.50M
Free Cash Flow	$ -128.84M	$ -170.25M	$ -226.24M	$ -139.25M	$ -152.12M	$ -102.69M
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in USD

Twist Bioscience Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing